France’s proposal to classify CBD as “reprotoxic” could lead to a broad European Union ban if the Scientific Committee on Consumer Safety (CSSC) confirms its harmful effects. This threatens the cosmetics, wellness, and CBD industries, potentially restricting consumer access to popular products. Companies and consumers may face significant challenges, with regulatory changes stifling innovation and growth.